Individualized treatment strategies for hyperuricemia informed by a semi-mechanistic exposure-response model of uric acid dynamics-Reference-Cited by-同舟云学术

Individualized treatment strategies for hyperuricemia informed by a semi-mechanistic exposure-response model of uric acid dynamics

Published:2018-02-27 Issue:5 Volume:6 Page:e13614
ISSN:2051-817X
Container-title:Physiological Reports
language:en
Short-container-title:Physiol Rep

Author:

Aksenov Sergey¹^ORCID,Peck Carl C.²,Eriksson Ulf G.³,Stanski Donald R.⁴

Affiliation:

1. Quantitative Clinical Pharmacology; Early Clinical Development; IMED Biotech Unit; AstraZeneca; Waltham MA

2. University of California at San Francisco and NDA Partners LLC; San Luis Obispo CA

3. Quantitative Clinical Pharmacology; Early Clinical Development; IMED Biotech Unit; AstraZeneca; Gothenburg Sweden

4. Quantitative Clinical Pharmacology; Early Clinical Development; IMED Biotech Unit; AstraZeneca; Gaithersburg MD

Publisher

Wiley

Subject

Physiology (medical),Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.14814/phy2.13614/fullpdf

Reference46 articles.

1. Renal Basis of Hyperuricemia

2. Definition of hyperuricemia and gouty conditions;Bardin;Curr. Opin. Rheumatol.,2014

3. Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study);Bardin;Ann. Rheum. Dis.,2017

4. Bhattaram , V. A. J. Gobburu 2017 Pharmacometrics Review, Clinical Pharmacology Biopharmaceutics Review, Uloric (Febuxostat) Tablets [Online] https://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/021856s000TOC.cfm

5. Uric acid metabolism in normal subjects and in gouty patients by chromatographic measurement of 14C-uric acid in plasma and urine;Bianchi;Metabolism,1979

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation framework for systems models;CPT: Pharmacometrics & Systems Pharmacology;2022-01-10

2. A semi-mechanistic exposure–response model to assess the effects of verinurad, a potent URAT1 inhibitor, on serum and urine uric acid in patients with hyperuricemia-associated diseases;Journal of Pharmacokinetics and Pharmacodynamics;2021-03-17

3. Anti-Hyperuricemic Effects of Astaxanthin by Regulating Xanthine Oxidase, Adenosine Deaminase and Urate Transporters in Rats;Marine Drugs;2020-12-01

4. Pink Urine Syndrome: A Combination of Insulin Resistance and Propofol;Kidney International Reports;2019-01

5. Aronia melanocarpa ameliorates gout and hyperuricemia in animal models;Food and Agricultural Immunology;2018-11-19